Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
05 Mar 2021
05 Mar 2021
Historique:
pubmed:
28
1
2021
medline:
28
1
2021
entrez:
27
1
2021
Statut:
epublish
Résumé
Neutralizing antibodies targeting the receptor binding domain (RBD) of the SARS-CoV-2 Spike (S) are among the most promising approaches against coronavirus disease 2019 (COVID-19)
Identifiants
pubmed: 33501434
doi: 10.1101/2021.01.22.427567
pmc: PMC7836104
pii:
doi:
Types de publication
Preprint
Langues
eng